These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 10565524)

  • 1. Is neuroprotection a viable therapy for glaucoma?
    Weinreb RN; Levin LA
    Arch Ophthalmol; 1999 Nov; 117(11):1540-4. PubMed ID: 10565524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current understanding of neuroprotection in glaucoma.
    Wein FB; Levin LA
    Curr Opin Ophthalmol; 2002 Apr; 13(2):61-7. PubMed ID: 11880717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we treat the brain in glaucoma?
    Gupta N; Yücel YH
    Can J Ophthalmol; 2007 Jun; 42(3):409-13. PubMed ID: 17508036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection in glaucoma: recent and future directions.
    Danesh-Meyer HV
    Curr Opin Ophthalmol; 2011 Mar; 22(2):78-86. PubMed ID: 21252670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
    Yamamoto T
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal ganglion cells and neuroprotection for glaucoma.
    Levin LA
    Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S21-4. PubMed ID: 12852431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
    Almasieh M; Levin LA
    Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glaucoma as primary optic neuropathy].
    Nicolae A; Stefan C
    Oftalmologia; 2001; 54(4):5-8. PubMed ID: 12035602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Strategies in Glaucoma.
    Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
    Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel inhibitors for the treatment of glaucoma.
    Cholkar K; Trinh HM; Pal D; Mitra AK
    Expert Opin Drug Discov; 2015 Mar; 10(3):293-313. PubMed ID: 25575654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection in Optic Neuropathy.
    Levin LA
    Asia Pac J Ophthalmol (Phila); 2018; 7(4):246-250. PubMed ID: 30066502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies.
    Marcic TS; Belyea DA; Katz B
    Curr Opin Ophthalmol; 2003 Dec; 14(6):353-6. PubMed ID: 14615639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement.
    Chang EE; Goldberg JL
    Ophthalmology; 2012 May; 119(5):979-86. PubMed ID: 22349567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA; Peeples P
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection: the next breakthrough in glaucoma? Proceedings of the Third Annual Optic Nerve Rescue and Restoration Think Tank.
    Chew SJ; Ritch R
    J Glaucoma; 1997 Aug; 6(4):263-6. PubMed ID: 9264307
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroprotection for glaucoma: Requirements for clinical translation.
    Levin LA; Crowe ME; Quigley HA;
    Exp Eye Res; 2017 Apr; 157():34-37. PubMed ID: 27955999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy.
    Vorwerk CK; Gorla MS; Dreyer EB
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S142-50. PubMed ID: 10416757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockers.
    Chen YS; Green CR; Danesh-Meyer HV; Rupenthal ID
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):182-93. PubMed ID: 25676338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.